Oculis Holding AG
F:CR5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oculis Holding AG
F:CR5
|
CH |
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
A
|
Air Water Inc
F:0AW
|
JP |
|
A
|
Ameresco Inc
SWB:4AM
|
US |
|
Lintec Corp
F:57T
|
JP |
|
Biomea Fusion Inc
NASDAQ:BMEA
|
US |
|
Basf Se
F:BAS
|
DE |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XMUN:AIL
|
FR |
|
B
|
Basf Se
DUS:BAS
|
DE |
|
A
|
Aeroports de Paris SA
XMUN:W7L
|
FR |
|
M
|
Master Style PCL
SET:MASTER
|
TH |
|
B
|
Bollore SE
XMUN:BOP
|
FR |
Shareholder Yield
Current shareholder yield for CR5 is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CR5 Price
Oculis Holding AG
| Average Annual Return | 8.12% |
| Standard Deviation of Annual Returns | 2.68% |
| Max Drawdown | -69% |
| Market Capitalization | 826.8m EUR |
| Shares Outstanding | 46 440 000 |
| Percentage of Shares Shorted |
N/A
|
